TCM
FBRX icon

Tybourne Capital Management’s Forte Biosciences FBRX Stock Holding History

Tybourne Capital Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11.8M Hold
786,647
– – 38.15% 2
2025
Q2 		$10.2M Buy
786,647
+166,666
+27% +$1.43M 29.45% 1
2025
Q1 		$4.81M Hold
619,981
– – 20.42% 4
2024
Q4 		$14.1M Buy
619,981
+475,000
+328% +$5.65M 3.53% 11
2024
Q3 		$810K Sell
144,981
-1
-0% -$10 0.23% 30
2024
Q2 		$1.95M Hold
144,982
– – 0.4% 24
2024
Q1 		$2.52M Hold
144,982
– – 0.43% 18
2023
Q4 		$2.98M Hold
144,982
– – 0.44% 21
2023
Q3 		$2.4M Buy
+144,982
New +$3.21M 0.34% 19

Other funds holding FBRX

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Tybourne Capital Management's FBRX Position: Q3 2025 in Review

Tybourne Capital Management held its Forte Biosciences (FBRX) position steady in Q3 2025 at 786,647 shares worth $11.8M. The position accounts for 38.15% of the portfolio, ranked #2.

Tybourne Capital Management first reported a position in FBRX in Q3 2023 and has held it in 9 quarters since. The position peaked at $14.1M in Q4 2024. 42 funds tracked by Wall St. Rank hold FBRX as of Q3 2025.

  • Tybourne Capital Management held 786,647 shares of Forte Biosciences worth $11.8M as of Q3 2025.
  • Tybourne Capital Management left its Forte Biosciences share count unchanged in Q3 2025.
  • Forte Biosciences made up 38.15% of Tybourne Capital Management's portfolio in Q3 2025, its #2 holding.
  • Tybourne Capital Management first reported a position in Forte Biosciences in Q3 2023 and has held it in 9 quarters since.
  • Tybourne Capital Management's Forte Biosciences position peaked at $14.1M in Q4 2024.
  • 42 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2025.

Based on Tybourne Capital Management's 13F filing for Q3 2025, filed 6 Nov 2025.